Moxifloxacin Stada

Moxifloxacin, the active ingredient in Moxifloxacin Stada, is a fluoroquinolone antibiotic presented as an oral dosage form for oral use. It treats a range of serious bacterial infections in adult patients, including pneumonia, sinusitis, bronchitis exacerbations, skin infections, and intra‑abdominal infections.

GNH USA supplies Moxifloxacin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections in the respiratory, skin and intra‑abdominal systems. - Community‑acquired bacterial pneumonia: eradicates the causative pathogens and improves clinical outcomes. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute exacerbations of chronic bronchitis: shortens symptom duration and prevents complications. - Skin and skin structure infections: eliminates Gram‑negative and Gram‑positive organisms. - Intra‑abdominal infections: provides coverage for mixed aerobic and anaerobic bacteria.

Moxifloxacin may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or swelling, especially in the Achilles. - QT interval prolongation: risk of cardiac arrhythmias, monitor ECG in susceptible patients. - Severe allergic reaction: anaphylaxis, angioedema, or Stevens‑Johnson syndrome.

Before prescribing Moxifloxacin, clinicians should consider several safety measures. - Renal function assessment: adjust therapy in patients with impaired clearance. - Tendon monitoring: advise patients to report tendon pain or inflammation promptly. - QT prolongation risk: avoid use with other QT‑prolonging agents and in patients with known cardiac conduction disorders. - Elderly caution: increased susceptibility to adverse events; monitor closely. - Discontinue on severe hypersensitivity: stop treatment if signs of anaphylaxis appear. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Moxifloxacin can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption of the antibiotic. - Warfarin: may enhance anticoagulant effect and increase bleeding risk. - Theophylline: can raise serum theophylline concentrations, leading to toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of central nervous system stimulation. - Systemic corticosteroids: combined use may raise the chance of tendon disorders.